The remaining thirteen studies assessed fresh autologous cycles, again reporting a lower incidence of mild, moderate or severe OHSS with a GnRH agonist trigger when compared to hCG, but also a lower live birth rate (72). This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.